References
- Alomrani AH, Gamal AS, Amro AA, Mohamed B. 2015. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformableliposomes: in vitro skin penetration studies and antifungal efficacyusing Candida albicans as model. Colloids Surf B Biointerfaces. 121:74–81.
- Badran MM, Ehab IT, Moustafa MT, Saleh AA. 2014. Ultra-fine self nanoemulsifying drug delivery system for transdermal delivery of meloxicam: dependency on the type of surfactants. J Mol Liq. 190:16–22.
- Barry BW. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 14:101–114.
- Bouwstra JA, Honeywell-Nguyen PL. 2002. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev. 54(Suppl.1):41–55.
- Castangia I, Manca ML, Matricardi P, Catalán-Latorre A, Nácher A, Diez-Sales O, et al. 2015. Effects of ethanol and diclofenac on the organization of hydrogenated phosphatidylcholine bilayer vesicles and their ability as skin carriers. J Mater Sci: Mater Med. 26:137. doi: 10.1007/s10856-015-5443-1.
- Castangia I, Manca ML, Matricardi P, Sinico C, Lampis S, Fernãndez-Busquets X. 2013. Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles. Int J Pharm. 456:1–9.
- Cevc G, Vierl U. 2010. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release. 141:277–299.
- Chaudhary H, Rohilla A, Rathee P, Kumar V. 2013. Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers. Int J Biol Macromol. 55:246–253.
- Chen M, Liu X, Fahr A. 2010. Skin delivery of ferulic acid from different vesicular systems. J Biomed Nanotechnol. 6:577–585.
- Dragicevic-Curic N, Susanna G, Burkhard G, Sven W, Fahr A. 2010. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm. 384:100–108.
- Duangjit S, Obata Y, Sano H, Onuki Y, Opanasopit P, Ngawhirunpat T, et al. 2014. Comparative study of novel ultradeformable liposomes: menthosomes, transfersomes and liposomes for enhancing skin permeation of meloxicam. Biol Pharm Bull. 37:239–247.
- Dubey V, Mishra D, Jain NK. 2007. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. European J Pharm Biopharm. 67:398–405.
- El Maghraby GM, Williams AC, Barry BW. 2006. Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol. 58:415–429.
- El Maghraby GM, Williams AC, Barry BW. 2001. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol. 53:1311–1322.
- El Zaafarany GM, Gehanne AS, Samar AM, Nahed MD. 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 397:164–172.
- El-Menshawe SF, Hussein AK. 2013. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharm Dev Technol. 18:779–786.
- FDA, Meloxicam Approval Document. 2000. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-938-Mobic.cfm.
- Fleischmann R, Dalgin RP, Caldwell J, Hall D, Roszko P. 2000. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. Arch Intern Med. 160:2947–2954.
- Gambero A, Becker TI, Zago AS, De Oliveira AF, Pedrazzoli RJ. 2005. Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors. Inflammopharmacology. 13: 441–454.
- Gillet A, Lecomte F, Hubert P, Ducat E, Evrard B, Piel G. 2011. Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm. 79:43–53.
- Haidar ZS, Hamdy RC, Tabrizian M. 2008. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials. 29:1207–1215.
- Hiruta Y, Yoshiyuki H, Kumi K, Yasuko O, Yoshie M. 2006. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release. 113:146–154.
- Kapoor BS, Subbarao GV. 2011. Formulation development and characterization of itraconazole granules. Int J Pharm Sci Nanotechnol. 4:1497–1500.
- Khurana S, Jain NK, Bedi PM. 2013. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci. 92:383–392.
- Li G, Fan C, Li X, Fan Y, Wang X, Li M, Liu Y. 2012. Preparation and in vitro evaluation of tacrolimus-loaded ethosomes. ScientificWorld J. 2012:874053.
- López-Pinto JM, González-Rodríguez ML, Rabasco AM. 2005. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 298:1–12.
- Luger P, Daneck K, Engel W, Trummlitz G, Wagner K. 1996. Structure and physicochemical properties of meloxicam, anew NSAID. Eur J Pharm Sci. 4:175–187.
- Manca ML, Castangia I, Matricardi P, Lampis S, FernãndezBusquets X, Fadda AM. 2014. Molecular arrangements and interconnected bilayer formation induced by alcohol or polyalcohol in phospholipid vesicles. Colloids Surf B Biointerfaces.117:360–367.
- Marzio LD, Esposito S, Rinaldi F, Marianecci C, Carafa M. 2013. Polysorbate 20 vesicles as oral delivery system: in vitro characterization. Colloids Surf B Biointerfaces. 104:200–206.
- Menon GK. 2002. New insights into skin structure: scratching the surface. Adv Drug Deliv Rev. 54:3–17.
- Monteiro MS, Ozzetti RA, Vergnanini AL, de Brito-Gitirana L, Volpato NM, de Freitas ZM, Ricci-Júnior E, dos Santos EP. 2012. Evaluation of octyl p-methoxycinnamate included in liposomes and cyclodextrins in anti-solar preparations: preparations, characterizations and in vitro penetration studies. Int J Nanomedicine. 7:3045–3058.
- Dragicevic-Curic N, Susanna G, Burkhard G, Sven W, Fahr A. 2010. Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability.Int J Pharm JPharm. 384:100–108.
- Pabyton CG, Pereira MA, Cordeiro RBS, Cavalcanti IMF, Neto BB. 2013. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochimica Et Biophysica Acta. 1828:309–316.
- Parfitt K. 1999. Martindale: The Complete Drug Reference. 32nd ed. London, United Kingdom: Pharmaceutical Press. p. 52.
- Peeters J, Peter N, Jan PV, Pieter R, Marcus EB. 2002. Characterization of the Interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7. J Pharm Sci. 91:1414–1422.
- Prausnitz MR. 2004. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 56:581–587.
- Sanjay K, Gupta Y, Jain A, Amin S. 2008. Elastic liposomes bearing meloxicam-β-cyclodextrin for transdermal delivery. Curr Drug Del. 8:207–2014.
- Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, et al. 2012. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine. 8:440–451.
- Southwell D, Barry BW. 1983. Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols, and caffeine. J Invest Dermatol. 80:507–514.
- Thomas BJ, Finnin BC. 2004. The transdermal revolution. Drug Discov Today. 9:697–703.
- Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 65:403–18.
- Türck D, Roth W, Busch U. 1996. A review of the clinical pharmacokinetics of meloxicam. Br J Rheumatol. 35:13–16.
- Verma DD, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 258:141–151.
- Walters KA, Roberts MS. 1993. Veterinary applications of skin penetration enhancers. In: Walters KA, Hadgraft J, Eds. Pharmaceutical Skin Penetration Enhancement. New York: Marcel Dekker. pp. 345–364.
- Winter CA, Risley EA, Nuss GW. 1962. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 111:544–547.
- Xiang Y, Lina D, Yu L, Guiying F, Yiguang J. 2015. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother. 73:6–11.
- Zhang YT, Shen LN, Wu ZH, Zhao JH, Feng NP. 2014. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 471:449–452.
- Zheng W-S, Fang X-Q, Wang L-L, Zhang Y-J. 2012. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm. 436:291–298.
- Zhu X, Li F, Peng X, Zeng K. 2013. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery. Anesth Analg. 117:352–357.